contact us   |   career   |   sitemap
Seminar on Phase 1 Centre Development and Management (一期药物临床试验室建设与管理培训班)

In respond to the pressing need of high quality phase 1 centre for conducting bioequivalent (BE) study in China owing to the revamp of drug registration requirements by the CFDA in July 2015, GuangDong Pharmaceutical Association held a seminar: Phase 1 Centre Development and Management (一期药物临床试验室建设与管理培训班) on 30 June – 01 July 2017 in Dongguan People's Hospital. The two-day seminar focused on topics in relation to the development and quality management of phase 1 centre as well as operations and risk management of BE and phase 1 studies. HKU-CTC’s Managing Director talked about risk management of phase 1 centre and phase 1 studies, contract and insurance management for clinical studies, attracting over 150 participants from various provinces and cities outside Guangdong.